Physician profile
Michael David Patterson
NPI 1851654867
$138,326.76
in general payments reported to CMS, 2019-2025
36 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $8,000 · 2021: $15K · 2022: $7,579 · 2023: $22K · 2024: $32K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $69K · Food and Beverage: $5,266 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,184.38 |
| Food and Beverage | $5,266.05 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $43,754.03 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Stellaris Elite |
| Johnson & Johnson Surgical Vision, INC. | $39,118.74 | 2019-2025 | Compact Intuitiv, Ifs Advanced Femtosec Laser, Intralase Fs Femtosec Laser |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16,905.50 | 2019-2021 | |
| Ivantis, INC | $10,323.39 | 2019-2021 | |
| Sight Sciences, INC. | $8,318.35 | 2019-2021 | |
| Glaukos Corporation | $5,915.13 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idosetr, Idose |
| Carl Zeiss Meditec, INC. | $4,145.99 | 2019-2021 | |
| New World Medical,INC. | $3,288.98 | 2020-2025 | Kahook Dual Blade, Streamline, Clearpath |
| Abbvie INC. | $1,535.35 | 2022-2025 | |
| Allergan, INC. | $1,387.61 | 2019-2022 | |
| Alcon Vision LLC | $870.46 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Harrow Eye, LLC | $547.57 | 2023-2025 | Iheezo, Vevye |
| Carl Zeiss Meditec USA, INC. | $476.63 | 2021-2022 | |
| Genentech USA, INC. | $396.05 | 2023-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $289.40 | 2023-2025 | Syfovre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $206.75 | 2019-2025 | Eylea Hd, Eylea |
| Omeros Corporation | $192.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $84.04 | 2019-2022 | |
| Staar Surgical Company | $82.09 | 2019 | |
| Mallinckrodt Hospital Products INC. | $54.77 | 2022 | |
| Dompe US, INC. | $50.70 | 2019-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $50.56 | 2022-2025 | Cequa |
| Rayner Intraocular Lenses Limited | $44.96 | 2022-2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Biotissue Holdings INC. | $44.81 | 2019-2024 | |
| Alimera Sciences, INC. | $37.74 | 2022-2024 | Yutiq, Iluvien |
| Eyevance Pharmaceuticals LLC | $34.33 | 2020 | |
| Iridex Corporation | $32.52 | 2020-2022 | |
| Astellas Pharma US INC | $25.25 | 2025 | Izervay |
| Biogen, INC. | $17.70 | 2023 | |
| Horizon Therapeutics Plc | $15.60 | 2021 | |
| Ani Pharmaceuticals, INC. | $15.49 | 2024 | Purified Cortrophin Gel |
| Oyster Point Pharma, INC. | $15.33 | 2022 | |
| Lombart Brothers, INC. | $12.91 | 2019 | |
| Rxsight INC | $12.01 | 2022 | |
| Ocular Therapeutix, INC. | $11.97 | 2022 | |
| Eyepoint US, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.